From: A 19-Gene expression signature as a predictor of survival in colorectal cancer
 | Good survival n = 39 | Poor survival n = 39 | ||
---|---|---|---|---|
 | No (%) | No (%) | p value | |
Dukes’ | B | 22 (56.41) | 15 (38.46) | 0.173 ** |
C | 17 (43.59) | 24 (61.54) | Â | |
Gender | Male | 20 (51.28) | 20 (51.28) | 1.000 ** |
Female | 19 (48.72) | 19 (48.72) | Â | |
Age (year) | ≤50 | 4 (10.26) | 5 (12.82) | 0.235 ** |
>50 | 35 (89.74) | 34 (87.18) | Â | |
Race | Chinese | 29 (74.36) | 24 (61.54) | 0.226 * |
Malay | 9 (23.08) | 15 (38.46) | Â | |
Indian | 1 (2.56) | 0 | Â | |
Tumor differentiation | Well | 26 (66.67) | 15 (38.46) | 0.051 * |
Moderately | 5 (12.82) | 15 (38.46) | Â | |
Poorly | 1 (2.56) | 2 (5.13) | Â | |
Mucinous | 2 (5.13) | 4 (10.26) | Â | |
No record | 5 (12.82) | 3 (7.69) | Â | |
Clinical outcome | Alive | 34 (87.18) | 0 | 0.000 ** |
Dead | 5 (12.82) | 39 (100.00) | Â | |
Organ | Colon | 25 (64.10) | 21 (53.85) | 0.357 ** |
Rectum | 14 (35.90) | 18 (46.15) | Â |